Status:

COMPLETED

Comparison of Closed-loop Operation After Morning Meal With and Without Carbohydrate Counting

Lead Sponsor:

Institut de Recherches Cliniques de Montreal

Collaborating Sponsors:

McGill University

Montreal Children's Hospital of the MUHC

Conditions:

Type-1 Diabetes

Eligibility:

All Genders

18-65 years

Phase:

PHASE2

Brief Summary

Closed-loop strategy is composed of three components: glucose sensor to read glucose levels, insulin pump to infuse insulin and a dosing mathematical algorithm to decide on the required insulin dosage...

Eligibility Criteria

Inclusion

  • Males and females ≥ 18 and ≤ 65 years of old.
  • Clinical diagnosis of type 1 diabetes for at least one year. The diagnosis of type 1 diabetes is based on the investigator's judgment and medical history (e.g. history of acido-ketosis, etc.); C peptide level and antibody determinations are not needed.
  • The subject will have been on insulin pump therapy for at least 3 months.
  • Last (less than 3 months) HbA1c ≤ 12%.

Exclusion

  • Clinically significant nephropathy, neuropathy (especially clinically significant gastroparesis) or retinopathy as judged by the investigator.
  • Recent (\< 3 months) acute macrovascular event e.g. acute coronary syndrome or cardiac surgery.
  • Pregnancy.
  • Severe hypoglycemic episode within two weeks of screening.
  • • Medication likely to affect with the interpretation of the results: Prandase, Victoza, Byetta and Symlin
  • Known or suspected allergy to the trial products or meal contents.
  • Other serious medical illness likely to interfere with study participation or with the ability to complete the trial by the judgment of the investigator.
  • Failure to comply with team's recommendations (e.g. not willing to eat snack, not willing to change pump parameters, etc).
  • Unreliable carbohydrate counting
  • Problems with venous access

Key Trial Info

Start Date :

January 1 2012

Trial Type :

INTERVENTIONAL

End Date :

November 1 2012

Estimated Enrollment :

12 Patients enrolled

Trial Details

Trial ID

NCT01519102

Start Date

January 1 2012

End Date

November 1 2012

Last Update

December 10 2012

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Institut de Recherches Cliniques de Montréal (IRCM)

Montreal, Quebec, Canada, H2W 1R7